Treatment of Executive Function Deficits in autism spectrum disorder with repetitive transcranial magnetic stimulation: A double-blind, sham-controlled, pilot trial

Stephanie H Ameis, Daniel M Blumberger, Paul E Croarkin, Donald J Mabbott, Meng-Chuan Lai, Pushpal Desarkar, Peter Szatmari, Zafiris J Daskalakis, Stephanie H Ameis, Daniel M Blumberger, Paul E Croarkin, Donald J Mabbott, Meng-Chuan Lai, Pushpal Desarkar, Peter Szatmari, Zafiris J Daskalakis

Abstract

Background: In youth and young adults with autism spectrum disorder (ASD), executive function (EF) deficits may be a promising treatment target with potential impact on everyday functioning.

Objective: To conduct a pilot randomized, double-blind, parallel, controlled trial evaluating repetitive transcranial magnetic stimulation (rTMS) for EF deficits in ASD.

Method: In Toronto, Ontario (November 2014 to June 2017), a 20-session, 4-week course of 20 Hz rTMS targeting dorsolateral prefrontal cortex (DLPFC) (90%RMT) was compared to sham stimulation in 16-35 year-olds with ASD (28 male/12 female), without intellectual disability, who had impaired everyday EF performance (n = 20 active/n = 20 sham). Outcome measures evaluated protocol feasibility and clinical effects of active vs. sham rTMS on EF performance. The moderating effect of baseline functioning was explored.

Results: Of eligible participants, 95% were enrolled and 95% of randomized participants completed the protocol. Adverse events across treatment arms were mild-to-moderate. There was no significant difference between active vs. sham rTMS on EF performance. Baseline adaptive functioning moderated the effect of rTMS, such that participants with lower baseline functioning experienced significant EF improvement in the active vs. sham group.

Conclusions: Our pilot RCT demonstrated the feasibility and acceptability of using high frequency rTMS targeting DLPFC in youth and young adults with autism. No evidence for efficacy of active versus sham rTMS on EF performance was found. However, we found promising preliminary evidence of EF performance improvement following active versus sham rTMS in participants with ASD with more severe adaptive functioning deficits. Future work could focus on examining efficacy of rTMS in this higher-need population.

Clinical trial registration: Repetitive Transcranial Magnetic Stimulation (rTMS) for Executive Function Deficits in Autism Spectrum Disorder and Effects on Brain Structure: A Pilot Study; https://ichgcp.net/clinical-trials-registry/NCT02311751?term = ameis&rank = 1; NCT02311751. The trial was funded by: an American Academy of Child and Adolescent Psychiatry (AACAP) Pilot Research Award, the Innovation Fund from the Alternate Funding Plan of the Academic Health Sciences Centres of Ontario, and an Ontario Mental Health Foundation (OMHF) Project A Grant and New Investigator Fellowship.

Keywords: Autism; Clinical trial; Executive functioning; Intervention; Repetitive transcranial magnetic stimulation; Youth.

Crown Copyright © 2020. Published by Elsevier Inc. All rights reserved.

Figures

Fig. 1.
Fig. 1.
CONSORT flow diagram.
Fig. 2.
Fig. 2.
Change in spatial working memory performance in active and sham rTMS groups. across baseline (Pre: n = 20 active, n = 20 sham), post rTMS (Post: n = 18 active, n = 20 sham) and one-month follow-up (F-Up: n = 17 active, n = 17 sham) time-points. Spatial working memory = total number of errors on the spatial working memory test from the Cambridge Neuropsychological Test Automated Battery (CANTAB).
Fig. 3.
Fig. 3.
Change in BRIEF Metacognition Index in active and sham rTMS groupsacross baseline (Pre: n = 20 active, n = 20 sham), post rTMS (Post: n = 18 active, n = 20 sham) and one-month follow-up (F-Up: n = 17 active, n = 17 sham) time-points. Metacognition Index = Behavioral Rating Inventory for Executive Function Metacognition Index (higher scores denote more real-world executive function impairment).
Fig. 4.
Fig. 4.
Moderating effect of baseline adaptive functioning on change in spatial working memory performance following rTMS across baseline (Pre: n = 20 active, n = 20 sham), post rTMS (Post: n = 18 active, n = 20 sham) and one-month follow-up (F-Up: n = 17 active, n = 17 sham) time-points. The significant group-by-time-by-VABS-II (Vineland Adaptive Behavior Scale-II) adaptive composite score is presented in participants following a median split to depict differences in response in participants with low versus high baseline adaptive functioning. Error bars indicate the 95%CI for mean spatial working memory score (in the original scale of the outcome) at a given time point.
Fig. 5.
Fig. 5.
Moderating effect of gender on change in spatial working memory performance following rTMS across baseline (Pre: n = 20 active, n = 20 sham), post rTMS (Post: n = 18 active, n = 20 sham) and one-month follow-up (F-Up: n = 17 active, n = 17 sham) time-points. Spatial working memory = total number of errors on the spatial working memory test from the Cambridge Neuropsychological Test Automated Battery (CANTAB). Error bars indicate the 95%CI for mean spatial working memory score (in the original scale of the outcome) at a given time point.

References

    1. Lazoff T, Zhong L, Piperni T, Fombonne E. Prevalence of pervasive developmental disorders among children at the English Montreal School Board. Can J Psychiatr 2010. November;55(11):715–20.
    1. Howlin P, Goode S, Hutton J, Rutter M. Adult outcome for children with autism. JCPP (J Child Psychol Psychiatry) 2004. February;45(2):212–29.
    1. Howlin P, Moss P. Adults with autism spectrum disorders. Can J Psychiatr 2012. May;57(5):275–83.
    1. Tillmann J, San Jose Caceres A, Chatham CH, Crawley D, Holt R, Oakley B, et al. Investigating the factors underlying adaptive functioning in autism in the EU-AIMS Longitudinal European Autism Project. Autism Res 2019. April;12(4): 645–57.
    1. Lounds Taylor J, Dove D, Veenstra-VanderWeele J, Sathe NA, McPheeters ML, Jerome RN, et al. 2012. August
    1. Ameis SH, Daskalakis ZJ, Blumberger DM, Desarkar P, Drmic I, Mabbott DJ, et al. Repetitive transcranial magnetic stimulation for the treatment of executive function deficits in autism spectrum disorder: clinical trial approach. J Child Adolesc Psychopharmacol 2017. June;27(5):413–21.
    1. Pellicano E The development of executive function in autism. Autism Res Treat 2012;2012:146132.
    1. Demetriou EA, Lampit A, Quintana DS, Naismith SL, Song YJC, Pye JE, et al. Autism spectrum disorders: a meta-analysis of executive function. Mol Psychiatry 2018. May;23(5):1198–204.
    1. Gilotty L, Kenworthy L, Sirian L, Black DO, Wagner AE. Adaptive skills and executive function in autism spectrum disorders. Child Neuropsychol 2002. December;8(4):241–8.
    1. Szatmari P, Bartolucci G, Bremner R, Bond S, Rich S. A follow-up study of high-functioning autistic children. J Autism Dev Disord 1989. June;19(2):213–25.
    1. George MS, Padberg F, Schlaepfer TE, O’Reardon JP, Fitzgerald PB, Nahas ZH, et al. Controversy: repetitive transcranial magnetic stimulation or transcranial direct current stimulation shows efficacy in treating psychiatric diseases (depression, mania, schizophrenia, obsessive-complusive disorder, panic, posttraumatic stress disorder). Brain Stimul 2009. January;2(1):14–21.
    1. Blumberger DM, Vila-Rodriguez F, Thorpe KE, Feffer K, Noda Y, Giacobbe P, et al. Effectiveness of theta burstversus high-frequency repetitive transcranial magnetic stimulation in patients with depression (THREE-D): a randomised non-inferiority trial. Lancet 2018. April 28;391(10131):1683–92.
    1. Guse B, Falkai P, Wobrock T. Cognitive effects of high-frequency repetitive transcranial magnetic stimulation: a systematic review. J Neural Transm 2010. January;117(1):105–22.
    1. Mogg A, Purvis R, Eranti S, Contell F, Taylor JP, Nicholson T, et al. Repetitive transcranial magnetic stimulation for negative symptoms of schizophrenia: a randomized controlled pilot study. Schizophr Res 2007. July;93(1–3):221–8.
    1. Wolwer W, Lowe A, Brinkmeyer J, Streit M, Habakuck M, Agelink MW, et al. Repetitive transcranial magnetic stimulation (rTMS) improves facial affect recognition in schizophrenia. Brain Stimul 2014. Jul-Aug;7(4):559–63.
    1. Barr MS, Farzan F, Rajji TK, Voineskos AN, Blumberger DM, Arenovich T, et al. Can repetitive magnetic stimulation improve cognition in schizophrenia? Pilot data from a randomized controlled trial. Biol Psychiatry 2013. March 15;73(6):510–7.
    1. Barahona-Correa JB, Velosa A, Chainho A, Lopes R, Oliveira-Maia AJ. Repetitive transcranial magnetic stimulation for treatment of autism spectrum disorder: a systematic review and meta-analysis. Front Integr Neurosci 2018;12:27.
    1. Sokhadze EM, Baruth JM, Sears L, Sokhadze GE, El-Baz AS, Casanova MF. Prefrontal neuromodulation using rTMS improves error monitoring and correction function in autism. Appl Psychophysiol Biofeedback 2012. June;37(2):91–102.
    1. Sokhadze EM, El-Baz AS, Sears LL, Opris I, Casanova MF. rTMS neuromodulation improves electrocortical functional measures of information processing and behavioral responses in autism. Front Syst Neurosci 2014;8: 134.
    1. Enticott PG, Fitzgibbon BM, Kennedy HA, Arnold SL, Elliot D, Peachey A, et al. A double-blind, randomized trial of deep repetitive transcranial magnetic stimulation (rTMS) for autism spectrum disorder. Brain Stimul 2014. Mar-Apr;7(2):206–11.
    1. Cole MW, Reynolds JR, Power JD, Repovs G, Anticevic A, Braver TS. Multi-task connectivity reveals flexible hubs for adaptive task control. Nat Neurosci 2013. September;16(9):1348–55.
    1. Vogan VM, Morgan BR, Lee W, Powell TL, Smith ML, Taylor MJ. The neural correlates of visuo-spatial working memory in children with autism spectrum disorder: effects of cognitive load. J Neurodev Disord 2014;6(1):19.
    1. Lynch CJ, Breeden AL, You X, Ludlum R, Gaillard WD, Kenworthy L, et al. Executive dysfunction in autism spectrum disorder is associated with a failure to modulate frontoparietal-insular hub architecture. Biol Psychiatr Cogn Neurosci Neuroimag 2017. September;2(6):537–45.
    1. Luna B, Minshew NJ, Garver KE, Lazar NA, Thulborn KR, Eddy WF, et al. Neocortical system abnormalities in autism: an fMRI study of spatial working memory. Neurology 2002. September 24;59(6):834–40.
    1. Koshino H, Carpenter PA, Minshew NJ, Cherkassky VL, Keller TA, Just MA. Functional connectivity in an fMRI working memory task in high-functioning autism. Neuroimage 2005. February 1;24(3):810–21.
    1. Wang Y, Zhang YB, Liu LL, Cui JF, Wang J, Shum DH, et al. A meta-analysis of working memory impairments in autism spectrum disorders. Neuropsychol Rev 2017. March;27(1):46–61.
    1. Rosa M, Puig O, Lazaro L, Valles V, Lera S, Sanchez-Gistau V, et al. Broad cognitive profile in children and Adolescents with HF-ASD and in their siblings: widespread underperformance and its clinical and adaptive correlates. J Autism Dev Disord 2017July;47(7):2153–62.
    1. Pinkham AE, Morrison KE, Penn DL, Harvey PD, Kelsven S, Ludwig K, et al. Comprehensive comparison of social cognitive performance in autism spectrum disorder and schizophrenia. Psychol Med 2019. October 2:1–9.
    1. Daskalakis ZJ, Moller B, Christensen BK, Fitzgerald PB, Gunraj C, Chen R. The effects of repetitive transcranial magnetic stimulation on cortical inhibition in healthy human subjects. Exp Brain Res 2006. October;174(3):403–12.
    1. de Jesus DR, Favalli GPS, Hoppenbrouwers SS, Barr MS, Chen R, Fitzgerald PB, et al. Determining optimal rTMS parameters through changes in cortical inhibition. Clin Neurophysiol 2014. April;125(4):755–62.
    1. Kim SY, Appelbaum PS, Swan J, Stroup TS, McEvoy JP, Goff DC, et al. Determining when impairment constitutes incapacity for informed consent in schizophrenia research. Br J Psychiatry 2007. July;191:38–43.
    1. Lord C, Risi S, Lambrecht L, Cook EH Jr, Leventhal BL, DiLavore PC, et al. The autism diagnostic observation schedule-generic: a standard measure of social and communication deficits associated with the spectrum of autism. J Autism Dev Disord 2000. June;30(3):205–23.
    1. Benson N, Hulac DM, Kranzler JH. Independent examination of the wechsler adult intelligence scale-fourth edition (WAIS-IV): what does the WAIS-IV measure? Psychol Assess 2010. March;22(1):121–30.
    1. Rosenthal M, Wallace GL, Lawson R, Wills MC, Dixon E, Yerys BE, et al. Impairments in real-world executive function increase from childhood to adolescence in autism spectrum disorders. Neuropsychology 2013. January;27(1): 13–8.
    1. McClintock SM, Reti IM, Carpenter LL, McDonald WM, Dubin M, Taylor SF, et al. Consensus recommendations for the clinical application of repetitive transcranial magnetic stimulation (rTMS) in the treatment of depression. J Clin Psychiatry 2018. Jan-Feb;79(1).
    1. Rusjan PM, Barr MS, Farzan F, Arenovich T, Maller JJ, Fitzgerald PB, et al. Optimal transcranial magnetic stimulation coil placement for targeting the dorsolateral prefrontal cortex using novel magnetic resonance image-guided neuronavigation. Hum Brain Mapp 2010. November;31(11):1643–52.
    1. Sparrow SS, Cicchetti DV. Diagnostic uses of the Vineland adaptive behavior scales. J Pediatr Psychol 1985. June;10(2):215–25.
    1. Duncan L, Georgiades K, Wang L, Van Lieshout RJ, MacMillan HL, Ferro MA, et al. Psychometric evaluation of the Mini international neuropsychiatric interview for children and Adolescents (MINI-KID). Psychol Assess 2018. July;30(7):916–28.
    1. Keel JC, Smith MJ, Wassermann EM. A safety screening questionnaire for transcranial magnetic stimulation. Clin Neurophysiol 2001. April;112(4):720.
    1. Whitehead AL, Julious SA, Cooper CL, Campbell MJ. Estimating the sample size for a pilot randomised trial to minimise the overall trial sample size for the external pilot and main trial for a continuous outcome variable. Stat Methods Med Res 2016. June;25(3):1057–73.
    1. Selya AS, Rose JS, Dierker LC, Hedeker D, Mermelstein RJ. A practical guide to calculating cohen’s f(2), a measure of local effect size, from PROC MIXED. Front Psychol 2012;3:111.
    1. Wickham H ggplot2: elegant graphics for data analysis. New York: Springer-Verlag; 2009.
    1. Loomes R, Hull L, Mandy WPL. What is the male-to-female ratio in autism spectrum disorder? A systematic review and meta-analysis. J Am Acad Child Adolesc Psychiatry 2017. June;56(6):466–74.
    1. Craig F, Margari F, Legrottaglie AR, Palumbi R, de Giambattista C, Margari L. A review of executive function deficits in autism spectrum disorder and attention-deficit/hyperactivity disorder. Neuropsychiatric Dis Treat 2016;12: 1191–202.
    1. Dajani DR, Llabre MM, Nebel MB, Mostofsky SH, Uddin LQ. Heterogeneity of executive functions among comorbid neurodevelopmental disorders. Sci Rep 2016. November 9;6:36566.
    1. Rossi S, Hallett M, Rossini PM, Pascual-Leone A. Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research. Clin Neurophysiol 2009. December;120(12):2008–39.
    1. Fitzgerald PB, Fountain S, Daskalakis ZJ. A comprehensive review of the effects of rTMS on motor cortical excitability and inhibition. Clin Neurophysiol 2006. December;117(12):2584–96.
    1. Chatham CH, Taylor KI, Charman T, Liogier D’ardhuy X, Eule E, Fedele A, et al. Adaptive behavior in autism: minimal clinically important differences on the Vineland-II. Autism Res 2018. February;11(2):270–83.
    1. Lee EC, Whitehead AL, Jacques RM, Julious SA. The statistical interpretation of pilot trials: should significance thresholds be reconsidered? BMC Med Res Methodol 2014. March 20;14:41.
    1. Hasan A, Guse B, Cordes J, Wolwer W, Winterer G, Gaebel W, et al. Cognitive effects of high-frequency rTMS in schizophrenia patients with predominant negative symptoms: results from a multicenter randomized sham-controlled trial. Schizophr Bull 2016. May;42(3):608–18.
    1. Dlabac-de Lange JJ, Bais L, van Es FD, Visser BG, Reinink E, Bakker B, et al. Efficacy of bilateral repetitive transcranial magnetic stimulation for negative symptoms of schizophrenia: results of a multicenter double-blind randomized controlled trial. Psychol Med 2015. April;45(6):1263–75.
    1. Szatmari P, Georgiades S, Duku E, Bennett TA, Bryson S, Fombonne E, et al. Developmental trajectories of symptom severity and adaptive functioning in an inception cohort of preschool children with autism spectrum disorder. JAMA Psychiatr 2015. March;72(3):276–83.
    1. Kanne SM, Gerber AJ, Quirmbach LM, Sparrow SS, Cicchetti DV, Saulnier CA. The role of adaptive behavior in autism spectrum disorders: implications for functional outcome. J Autism Dev Disord 2011. August;41(8):1007–18.
    1. Ameis SH, Lerch JP, Taylor MJ, Lee W, Viviano JD, Pipitone J, et al. A diffusion tensor imaging study in children with ADHD, autism spectrum disorder, OCD, and matched controls: distinct and non-distinct white matter disruption and dimensional brain-behavior relationships. Am J Psychiatry 2016. December 1;173(12):1213–22.
    1. Plitt M, Barnes KA, Wallace GL, Kenworthy L, Martin A. Resting-state functional connectivity predicts longitudinal change in autistic traits and adaptive functioning in autism. Proc Natl Acad Sci U S A 2015. December 1;112(48): E6699–706.
    1. Hull L, Mandy W, Petrides KV. Behavioural and cognitive sex/gender differences in autism spectrum condition and typically developing males and females. Autism 2017. August;21(6):706–27.
    1. Lai MC, Lombardo MV, Auyeung B, Chakrabarti B, Baron-Cohen S. Sex/gender differences and autism: setting the scene for future research. J Am Acad Child Adolesc Psychiatry 2015. January;54(1):11–24.
    1. Lai MC, Lerch JP, Floris DL, Ruigrok AN, Pohl A, Lombardo MV, et al. Imaging sex/gender and autism in the brain: etiological implications. J Neurosci Res 2017. January 2;95(1–2):380–97.
    1. Huber TJ, Schneider U, Rollnik J. Gender differences in the effect of repetitive transcranial magnetic stimulation in schizophrenia. Psychiatry Res 2003. August 30;120(1):103–5.
    1. McConachie H, Parr JR, Glod M, Hanratty J, Livingstone N, Oono IP, et al. Systematic review of tools to measure outcomes for young children with autism spectrum disorder. Health Technol Assess 2015. June;19(41): 1–506.
    1. Lai MC, Kassee C, Besney R, Bonato S, Hull L, Mandy W, et al. Prevalence of co-occurring mental health diagnoses in the autism population: a systematic review and meta-analysis. Lancet Psychiatr 2019. October;6(10):819–29.

Source: PubMed

3
订阅